Detalhe da pesquisa
1.
Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.
J Am Soc Nephrol
; 32(12): 3252-3264, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706967
2.
Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression.
Transplant Direct
; 9(2): e1419, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700062
3.
Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies.
Clin Pharmacol Drug Dev
; 10(9): 1007-1017, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33955686
4.
GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1).
J Cyst Fibros
; 18(5): 693-699, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31147302
5.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial.
Lancet Respir Med
; 6(8): 627-635, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29792287